Sponsor or institution
Clinical trials and research at The First Affiliated Hospital with Nanjing Medical University
As of November 12, 2026, Find a Trial lists 147 clinical trials run by The First Affiliated Hospital with Nanjing Medical University that are recruiting, in China. 5 were first registered in the last 30 days. By phase: Phase 2 (52), Phase 3 (9), Phase 4 (8), Early Phase 1 (5). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 147Clinical trials
- 5New in 30 days
- 1Country
Newest trials
All recruiting trials (147)
-
Aspirin vs. rivaroxaban for blood clot prevention in newly diagnosed multiple myeloma
In newly diagnosed multiple myeloma patients on IMiD-based therapy, this study tests whether aspirin or rivaroxaban is better at preventing blood clots.
-
Chemotherapy sensitivity-guided Culmerciclib combo for HR+/HER2- breast cancer before surgery
This trial tests whether adding Culmerciclib to chemotherapy before surgery can help people with HR+/HER2- breast cancer who don’t respond to initial TAC treatment.
-
Off-clamp, sutureless robot-assisted partial nephrectomy vs conventional robot-assisted partial nephrectomy
This trial tests whether removing a small kidney tumor without clamping the blood supply and without stitching the kidney bed preserves kidney function better than the standard robot-assisted surgery.
-
Chidamide, Lenalidomide, and Rituximab as induction therapy for newly diagnosed elderly or unfit double-expressor DLBCL
This trial tests whether the combo of chidamide, lenalidomide, and rituximab can help treat newly diagnosed double-expressor DLBCL in people who are elderly or not fit for standard chemotherapy.
-
Real-world use of BCL-2 inhibitor regimens in CLL/SLL
This real-world study looks at how BCL-2 inhibitors are used and how patients with CLL or SLL fare in routine clinical practice.
-
Perioperative therapy with Retlirafusp alfa, Famitinib, and HAIC-GEMOX for locally advanced intrahepatic cholangiocarcinoma
This trial tests whether a perioperative treatment combo (Retlirafusp alfa, famitinib, and HAIC-GEMOX) can help shrink or control locally advanced intrahepatic cholangiocarcinoma before surgery and support additional therapy afterward in adults.
-
Heart Rate Variability Changes and Delirium After Major Abdominal Surgery
This study looks at whether early changes in resting heart rate variability can signal the development of postoperative delirium in older adults after major abdominal surgery.
-
Short-course radiotherapy with Adebrelimab and platinum chemo before surgery for locally advanced cervical cancer
This trial tests a short course of radiotherapy combined with Adebrelimab and platinum chemotherapy to shrink locally advanced cervical cancer before surgery.
-
Orelabrutinib with Obinutuzumab and Short-Course Venetoclax in Treatment-Naïve Mantle Cell Lymphoma
This trial tests whether a combo of orelabrutinib, obinutuzumab, and a short course of venetoclax is safe and effective for adults with newly diagnosed mantle cell lymphoma.
-
Immunotherapy plus Simvastatin and Targeted Therapy with Chemotherapy for Advanced Colorectal Cancer
This trial tests whether adding immune therapy (adbelimumab? actually Adebrelimab) with simvastatin and targeted therapy to standard chemotherapy helps people with metastatic colorectal cancer that is MSI-H/dMMR or MSS/pMMR depending on combination.
-
Platelet Membrane–Coated Tenecteplase for Arterial Clots
This study tests whether a platelet membrane–coated form of tenecteplase can dissolve arterial clots in humans and whether blood from patients on antiplatelet therapy affects its clot-busting ability.
-
Breast ultrasound screening for older women in community clinics
This study tests whether offering breast ultrasound to women aged 65–80 in local communities helps find breast cancers earlier than usual care.
-
Dihydroartemisinin for MAFLD in Adults
This study tests whether the malaria drug dihydroartemisinin can reduce liver fat in adults with MAFLD.
-
MRD-guided Zanubrutinib + Sonrotoclax in new high-risk CLL/SLL
This trial tests a time-limited, MRD-guided combination therapy with zanubrutinib and sonrotoclax for adults up to 75 with previously untreated high-risk CLL/SLL.
-
First-line combination therapy with adebrelimab, gemcitabine, and nab-paclitaxel for biliary tract cancers
A multicenter, single-arm study tests whether a PD-1 blocker (adebrelimab) plus chemotherapy (gemcitabine and nab-paclitaxel) is safe and effective as first-line treatment for biliary tract cancers that can’t be surgically removed.
-
Intra-arterial Thrombolysis for Acute Ischemic Stroke with Medium Vessel Occlusion
This trial tests whether delivering a clot-busting medicine directly into the brain’s medium vessels helps improve outcomes for adults with acute ischemic stroke caused by MeVO, on top of standard care.
-
Different-Dose Short-Course Radiotherapy With CAPOX, PD-1 Blockade, and IL-2 in Locally Advanced Rectal Cancer
This phase II trial tests whether a low-dose short-course radiotherapy combined with CAPOX, a PD-1 blocker, and IL-2 works as well as the standard-dose short-course approach in patients with locally advanced rectal cancer.
-
Maintenance with QL1706 after chemo in high-risk triple-negative breast cancer
This study tests whether adding QL1706 after standard chemotherapy can help people with high-risk triple-negative breast cancer stay cancer-free longer.
-
Polatuzumab vedotin with Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in untreated DLBCL (MCD/BN2/N1)
This study tests a targeted combination therapy to see if it can treat previously untreated DLBCL with specific molecular subtypes.
-
GLP-1 receptor agonists for diabetic cardiac autonomic neuropathy in type 2 diabetes
This study will try once-weekly semaglutide or polyethylene glycol loxenatide plus usual care to see if they improve heart nerve function in adults with type 2 diabetes who have diabetic cardiac autonomic neuropathy.
-
Anti-CD19/BCMA universal CAR-T cell therapy for refractory autoimmune diseases
This will try anti-CD19/BCMA universal CAR-T cell therapy in adults with refractory rheumatoid arthritis, dermatomyositis, systemic lupus, or systemic sclerosis to see if it is safe and can control their disease.
-
Perirenal SC101 injection to lower blood pressure in resistant hypertension with moderate–severe CKD
This trial will test whether a single injection of SC101 into the fat around the kidneys can lower blood pressure in adults with resistant hypertension and stage 3–4 chronic kidney disease.
-
Different dosing schedules of ceftazidime‑avibactam plus aztreonam for carbapenem‑resistant Gram‑negative infections
This trial tests different dosing schedules of ceftazidime‑avibactam plus aztreonam to see which works best for adults with metallo‑β‑lactamase–producing, carbapenem‑resistant Gram‑negative infections.
-
Disitamab vedotin plus SOX versus SOX alone as adjuvant treatment for HER2-moderate/high stage III gastric cancer after surgery
This trial will test whether adding disitamab vedotin to standard SOX chemotherapy helps people with HER2-moderate/high stage III gastric cancer after surgery stay cancer-free longer or live longer.
-
Shr-1701 with or without Apatinib plus chemotherapy as neoadjuvant treatment for gastric cancer
This trial tests whether adding SHR-1701, with or without apatinib, to chemotherapy before surgery helps patients with resectable locally advanced gastric or gastroesophageal junction cancer.
-
Bemosubaiabimab plus anlotinib with radiotherapy and chemotherapy for oligometastatic esophageal cancer
This trial tests whether adding bemosubaiabimab to anlotinib together with radiotherapy and chemotherapy helps people with oligometastatic esophageal squamous cell carcinoma.
-
Orelabrutinib plus rituximab with optional lenalidomide for untreated marginal zone lymphoma using a response-adapted plan
This will test whether giving orelabrutinib with rituximab, and adding lenalidomide for those who don't fully respond, helps people with newly diagnosed marginal zone lymphoma achieve complete remissions.
-
Disitamab vedotin plus bevacizumab for HER2-low metastatic breast cancer after T‑DxD failure
This study will try disitamab vedotin combined with bevacizumab in adults with HER2‑low metastatic breast cancer whose disease progressed after trastuzumab deruxtecan.
-
HRS-4642 with nab-paclitaxel and gemcitabine as conversion therapy for KRAS G12D locally advanced pancreatic cancer
This treatment combination will be tested to see if adding HRS-4642 to nab-paclitaxel and gemcitabine can shrink tumors enough to allow surgery in adults with locally advanced pancreatic cancer who have a KRAS G12D mutation.
-
Zanubrutinib, rituximab, lenalidomide plus tislelizumab for relapsed/refractory follicular lymphoma
This trial tests whether adding the PD‑1 blocker tislelizumab to zanubrutinib, rituximab, and lenalidomide helps adults with relapsed or refractory follicular lymphoma who have had at least two prior therapies.
-
Transplanting hiPSC-derived RPE Cells for Advanced AMD
This trial tests whether transplanting lab-made retinal pigment epithelium cells can help people aged 50–85 with late-stage AMD see if their condition improves or stabilizes.
-
PD‑1 blocker with rituximab, high‑dose methotrexate, and orelabrutinib for newly diagnosed primary or secondary CNS lymphoma
This trial will test whether combining a PD‑1 blocker with rituximab, high‑dose methotrexate, and orelabrutinib helps people with newly diagnosed primary or secondary central nervous system diffuse large B‑cell lymphoma.
-
Robotic removal of stomach GISTs in difficult anatomic locations
This study will try robotic radical surgery to remove localized gastric GISTs 2–5 cm located at special anatomic sites in adults who have not received prior neoadjuvant therapy.
-
Ferumoxytol-enhanced heart MRI to find calcified coronary arteries
This research will see if ferumoxytol-enhanced heart MRI can detect calcified coronary arteries in adults who already have calcification on coronary CT angiography.
-
Radiation with anlotinib for HER2-negative breast cancer brain metastases
This trial tests whether adding the drug anlotinib to stereotactic or whole-brain radiotherapy (with a microtubule inhibitor) helps people with HER2-negative breast cancer that has spread to the brain.
-
Focused ultrasound (HIFU) with or without a PD‑1 immune drug before Abraxane and carboplatin in triple‑negative breast cancer
This study will try focused ultrasound (HIFU) with or without the immune drug sintilimab before standard chemotherapy to see if people with early-stage triple‑negative breast cancer can achieve a complete tumor response.
-
Remimazolam-based anesthesia to reduce delirium after laparoscopic gastrectomy in older adults
This study tests whether using remimazolam instead of propofol-based anesthesia lowers delirium after surgery in patients 65 and older undergoing laparoscopic gastrectomy for gastric cancer.
-
LVIVO-TaVec200 for relapsed or refractory multiple myeloma
This trial will try LVIVO-TaVec200, a new investigational product, in adults with relapsed or refractory multiple myeloma who have received at least three prior therapies.
-
Preoperative thymalfasin plus PD-1 antibody with chemo‑radiation for cStage III gastroesophageal junction adenocarcinoma
This trial will test whether adding thymalfasin and a PD-1 antibody to preoperative chemotherapy and radiation helps people with resectable, locally advanced (cStage III) gastroesophageal junction adenocarcinoma.
-
Intrathecal thiotepa plus trastuzumab for HER2‑positive breast cancer with leptomeningeal metastasis
Testing whether injecting thiotepa together with trastuzumab into the cerebrospinal fluid through an Ommaya reservoir helps people with HER2‑positive breast cancer that has spread to the leptomeninges.
-
GLOW Plan: Predicting and Preventing Gestational Diabetes with Lifestyle Support and Glucose Monitoring
This project will test whether combining continuous glucose monitoring, regular self-monitoring, and personalized lifestyle support can help predict and reduce gestational diabetes in pregnant people aged 18–40 who receive care at the participating hospital.
-
Sintilimab added to SOX chemotherapy after surgery for PD-L1–positive pN3 gastric cancer
This trial will test whether adding the PD-1 blocker sintilimab to standard SOX chemotherapy after surgery helps people with PD-L1–positive, pathologic N3 gastric cancer stay cancer-free longer.
-
AI-assisted CT detection and staging of stomach cancer
This project will test an AI tool that reads routine contrast-enhanced CT scans to detect stomach cancer and assign T1–T4 and N0–N3 stages before surgery.
-
Glofitamab plus PD‑1 antibody and lenalidomide for relapsed/refractory TP53‑aberrant large B‑cell lymphoma
This trial will test whether combining glofitamab with a PD‑1 antibody and lenalidomide can help adults with relapsed or refractory large B‑cell lymphoma that has TP53 mutations or deletions.
-
7-day vonoprazan with high-dose amoxicillin plus bismuth for H. pylori
This trial tests whether adding bismuth to a 7-day vonoprazan plus high-dose amoxicillin regimen can cure H. pylori infection in adults 18–70 who have not had prior eradication therapy.
-
Whole-body MRI for non-invasive lesion detection and therapy follow-up in radiographic and non-radiographic axial spondyloarthritis
This project will try whole-body MRI to find lesions and track treatment response in people with radiographic or non-radiographic axial spondyloarthritis.
-
Orelabrutinib plus zebetuzumab and lenalidomide vs bendamustine‑rituximab for newly diagnosed marginal zone lymphoma
This study will test whether a combination of orelabrutinib, zebetuzumab, and lenalidomide helps people with newly diagnosed marginal zone lymphoma compared with a standard bendamustine plus rituximab regimen.
-
Ultrasound-enhanced delivery of tranexamic acid and glutathione for facial melasma
This trial will test whether using ultrasound to help the skin absorb a 10% tranexamic acid and 2% glutathione solution reduces facial melasma in adults aged 20–55.
-
Linperlisib plus CPT (cyclophosphamide, prednisone, thalidomide) for relapsed or refractory non-Hodgkin lymphoma
This trial tests whether adding linperlisib to a CPT regimen helps adults with relapsed or refractory non-Hodgkin lymphoma.
-
Acoustic stimulation treatment for chronic tinnitus
This trial will try acoustic sound stimulation to reduce ringing for adults whose tinnitus has lasted six months or longer.
-
Autologous NK cell therapy KN5001 for pulmonary nodules.
This test tries KN5001, made from your own NK cells, to see if it is safe and can help adults (18–70) who have malignant or high‑risk lung nodules that cannot be removed surgically or have failed other treatments.
-
Off-clamp, sutureless robot-assisted partial nephrectomy for small kidney tumors
This will try a robot-assisted partial nephrectomy that avoids artery clamping and sutures to better preserve kidney function in adults with renal tumors up to 7 cm.
-
Fixed-duration zanubrutinib plus bendamustine and obinutuzumab for newly diagnosed advanced follicular lymphoma
This tests a six-cycle combination of zanubrutinib, bendamustine, and obinutuzumab for adults with newly diagnosed advanced-stage follicular lymphoma.
-
Omitting the extra tumor‑bed boost after breast‑conserving surgery for patients who achieve a complete response to neoadjuvant chemotherapy
This study will try skipping the extra 'boost' radiation to the tumor bed in people with breast cancer who achieve a pathologic complete response after neoadjuvant chemotherapy and breast‑conserving surgery to see if it's safe and lowers treatment side effects.
-
How pet cats change the nose and gut microbiome in people with cat allergies
This project tests whether living with a pet cat changes the nasal and gut microbiomes in adults with allergic rhinitis who are sensitized to cat allergens.
-
RN1201: a one-time CAR-T therapy for autoimmune diseases that haven’t responded to standard treatments
This open-label, early-stage trial tests a single infusion of RN1201 CAR-T cells in adults with autoimmune diseases not adequately controlled by standard therapies.
-
RC48 with bevacizumab or pyrotinib for HER2-positive metastatic breast cancer after T-Dxd failure
This trial will try RC48 together with either bevacizumab or pyrotinib in adults with HER2-positive metastatic breast cancer whose disease has progressed after trastuzumab deruxtecan (T-Dxd).
-
Minimally invasive D2+PAND gastrectomy after immunochemotherapy for gastric or GEJ cancer with para‑aortic node enlargement
This trial will try whether four cycles of a PD‑1 immunotherapy plus SOX chemotherapy followed by minimally invasive gastrectomy with D2+PAND lymphadenectomy can enable curative surgery for people with HER2‑negative gastric or gastroesophageal junction cancer and enlarged para‑aortic (No.16) lymph nodes.
-
Constant 5% versus sequential 5% to 2% oxygen for embryo culture in IVF
This will test whether keeping embryos at a constant 5% oxygen level or lowering oxygen from 5% to 2% during culture changes term live birth rates for women undergoing blastocyst IVF.
-
Risk factors for rupture of flow-related aneurysms in posterior brain AVMs
This project tries to find which clinical and imaging features make flow-related aneurysms in posterior brain arteriovenous malformations more likely to rupture in people with subarachnoid hemorrhage.
-
Need for a second transurethral resection in high-risk NMIBC patients with negative urine genome-wide low-depth sequencing after initial resection
This trial will test whether people with high-risk non-muscle-invasive bladder cancer who have a negative urine genome-wide low-depth sequencing result can safely skip a planned second transurethral resection.
-
AI-driven real-time 3D kidney model to assist partial nephrectomy
This trial will test whether an AI-powered real-time 3D kidney model can help surgeons perform laparoscopic or robotic partial nephrectomy for adults with small, localized kidney tumors.
-
LVIVO-TaVec100 for relapsed or refractory B-cell malignancies
This Phase 1 study will test a single dose of LVIVO-TaVec100 to see if it is safe and helps adults with relapsed or refractory B-cell malignancies.
-
Optimizing diagnosis of chronic rhinitis with a nasal allergen provocation test
This project will test whether a nasal allergen provocation test helps diagnose adults with chronic rhinitis by comparing patients with suspected allergic rhinitis to healthy volunteers.
-
Nimotuzumab combined with chemoradiotherapy for elderly patients with esophageal cancer
This study is testing if adding a new drug called nimotuzumab to standard treatment helps older patients with advanced esophageal cancer feel better and live longer.
-
Using venetoclax to treat CLL patients on BTK inhibitors
This study is testing if adding venetoclax to the treatment of chronic lymphocytic leukemia (CLL) patients already on BTK inhibitors can help improve their condition after six months of treatment.
-
New treatment approach for Helicobacter pylori infection
This study is testing a new two-phase treatment for Helicobacter pylori infection that combines a stomach medication with higher doses of antibiotics to see if it works better and is easier for patients to handle than the usual treatment.
-
Robot-assisted surgery for early-stage kidney tumors
This study is testing whether robot-assisted surgery without clamping the renal artery can safely and effectively treat early-stage kidney tumors while helping patients recover faster and keep their kidney function.
-
Robotic removal of stomach tumors after pre-surgery chemotherapy for advanced gastric cancer
This trial tests whether robotic stomach cancer surgery after 3–4 cycles of preoperative therapy is safe and helps people with stage III resectable gastric or gastroesophageal junction adenocarcinoma.
-
Combining Chidamide with R-CHOP for a specific type of lymphoma
This study is testing if adding a new drug called chidamide to standard chemotherapy can help people with a specific type of lymphoma feel better and live longer.
-
Tislelizumab plus anlotinib as a second-line treatment for thymoma and thymic carcinoma
This trial will test whether combining tislelizumab with anlotinib is safe and can control thymoma or thymic carcinoma in people whose cancer progressed after first-line chemotherapy (with or without immunotherapy).
-
Comparing hypofractionated and conventional radiation for breast cancer patients with implants
This study is testing whether a shorter, more intense radiation treatment is safer and more effective than standard radiation for women with breast implants after mastectomy for breast cancer.
-
Evaluating endoscopic-assisted mastectomy with immediate breast reconstruction for breast cancer
This study is testing a new way to perform mastectomy with immediate breast reconstruction using advanced technology to see if it helps breast cancer patients recover better than traditional methods.
-
Evaluating Pyrotinib for HER2-positive Advanced Breast Cancer
This study is testing if a new drug called Pyrotinib, given with standard chemotherapy, can help people with advanced HER2-positive breast cancer feel better and improve their treatment outcomes.
-
Effect of Lenvatinib on High-risk Liver Cancer Recurrence After Surgery
This study is testing if the drug lenvatinib can help prevent liver cancer from coming back after surgery in patients at high risk for recurrence.
-
Romiplostim N01 versus recombinant human interleukin-11 for cancer therapy–induced thrombocytopenia
This trial will test whether romiplostim N01 or recombinant human interleukin-11 better raises platelet counts in adults with cancer therapy–induced thrombocytopenia.
-
Using AI to predict kidney function after partial kidney removal
This study is testing if a new AI tool can accurately predict how well your kidneys will work after you have part of one removed due to cancer.
-
Bladder-sparing treatment for large non-muscle-invasive bladder cancer
This study is testing new bladder-sparing treatments for people with large non-muscle-invasive bladder cancer to see if they can improve outcomes while keeping the bladder intact.
-
Evaluating antiplatelet therapy for cerebral small vessel diseases
This study is testing if different blood-thinning medications can help people aged 30 to 79 with small vessel disease in the brain feel better and improve their condition.
-
Improving management of renal tumors using artificial intelligence
This study is testing if using artificial intelligence can help doctors better understand and treat kidney tumors by analyzing CT scans and improving surgical decisions.
-
Effect of Lupatadine Fumarate on Allergic Rhinitis
This study is testing if Lupatadine Fumarate can help adults with allergic rhinitis feel better by reducing their symptoms like nasal congestion.
-
Using trilaciclib to prevent bone marrow suppression in esophageal cancer treatment
This study is testing if giving trilaciclib before chemotherapy can help prevent bone marrow problems in people with esophageal cancer.
-
Combining Clostridium Butyricum with PD1 inhibitors for bladder cancer treatment
This study is testing if adding Clostridium butyricum to PD1 inhibitors can help improve treatment results for bladder cancer patients.
-
Combining donafenib and capecitabine for treating high-risk biliary cancer after surgery
This study is testing if combining donafenib with capecitabine can help prevent high-risk biliary cancer from coming back after surgery.
-
Parastomal Hernia After Mesenteric Molding Suturing in Colostomy
This study tests whether mesenteric molding suturing reduces parastomal hernias after colostomy compared with non-molding suturing in adults.
-
Effects of long-term vagus nerve stimulation in early Parkinson's disease
This study is testing if a new type of nerve stimulation can help people with early Parkinson's disease slow down the progression of their symptoms.
-
Using CD19 CAR NK cells to treat refractory antisynthetase antibody syndrome and rheumatoid arthritis
This study tests if a new treatment using special immune cells can help people with tough cases of antisynthetase antibody syndrome and rheumatoid arthritis feel better.
-
Combining Adebrelimab with Capecitabine for High-Risk Cholangiocarcinoma After Surgery
This study is testing if combining a new immunotherapy drug with a chemotherapy drug can help prevent cancer from coming back in adults with high-risk cholangiocarcinoma after surgery.
-
Individualized exercise program for elderly patients with coronary heart disease
This study tests whether a personalized exercise program can help older patients with coronary heart disease feel better physically and mentally.
-
Comparing robot-assisted kidney surgery in different positions
This study is testing if having kidney surgery with a robot while lying face down is better for recovery and results compared to the usual side position for patients with kidney tumors.
-
Combining sintilimab with chemotherapy for treating esophageal cancer before surgery
This study is testing if giving a new immunotherapy along with chemotherapy before surgery can help people with esophageal cancer have better outcomes.
-
Sintilimab combined with chemoradiotherapy for elderly patients with advanced gastric cancer
This study is testing if a new combination of a drug called sintilimab with chemotherapy and radiation can help older patients with advanced stomach cancer feel better and improve their quality of life.
-
Using Thiotepa and Methotrexate for Breast Cancer with Leptomeningeal Metastasis
This study is testing if a combination of thiotepa and methotrexate can help people with breast cancer that has spread to the protective layers around the brain feel better and live longer.
-
Evaluating the impact of PCI on patients with chronic coronary artery occlusion
This study is testing if a heart procedure called PCI can help people with chronic coronary artery blockages live longer and have fewer serious heart problems compared to those who only receive medication.
-
Comparing two methods of catheter ablation for long-standing persistent atrial fibrillation
This study is testing if a new method of heart procedure can help people with long-standing atrial fibrillation feel better compared to a standard procedure.
-
Comparing two treatment options for elderly patients with newly diagnosed multiple myeloma
This study is testing two different treatment options for older patients with newly diagnosed multiple myeloma to see which one works better and is safer.
-
Using sequencing to predict outcomes of pneumonia in ventilated patients
This study is testing if analyzing germs in the lungs of patients on ventilators can help predict how well they will recover from pneumonia.
-
Combining anti-PD-1 therapy with thymalfasin and chemotherapy for advanced gastric cancer treatment
This study is testing a new combination of treatments for people with advanced stomach cancer to see if it helps shrink tumors before surgery.
-
Effects of GLP-1RA on heart health in diabetes patients
This study is testing if a diabetes medication called Semaglutide can improve heart health and symptoms related to heart issues in people with type 2 diabetes.
-
Exploring the effects of ZhenQiFuZheng granules on allergic rhinitis
This study is testing if ZhenQi FuZheng granules can help people with allergic rhinitis by looking at how they affect gut bacteria and inflammation.
-
Combining irinotecan liposome with oxaliplatin and tegafur for pancreatic cancer treatment
This study tests if a new combination of chemotherapy drugs can help people who have had surgery for pancreatic cancer recover better and stay cancer-free longer.
-
Exploring fertility preservation and health outcomes in female cancer patients
This study is testing if women with cancer who take steps to save their ability to have children before treatment have better chances of having healthy babies compared to those who don’t and to women without cancer.
-
Nocardia rubra cell wall skeleton added to prior second- or third-line therapy for potentially hazardous stable colorectal cancer
This test tries adding Nocardia rubra cell wall skeleton to prior second- or third-line treatments for adults with advanced colorectal cancer who have a potentially hazardous stable disease to see if it better controls their cancer.
-
Cadonilimab with paclitaxel micelles and cisplatin before surgery for locally advanced esophageal squamous cancer
This trial will test whether giving cadonilimab together with paclitaxel polymeric micelles and cisplatin before surgery helps people with locally advanced esophageal squamous cell carcinoma.
-
Combining Serplulimab with Chemoradiotherapy for Elderly Patients with Advanced Esophageal Cancer
This study is testing if combining a new drug called Serplulimab with standard chemotherapy and radiation can help older patients with advanced esophageal cancer who can't have surgery feel better and live longer.
-
Combining surgery with hormone therapy for advanced prostate cancer
This study is testing if combining surgery with hormone therapy and possibly chemotherapy can help men with advanced prostate cancer live longer without their cancer getting worse.
-
Evaluating dalpiciclib with endocrine therapy for early breast cancer treatment
This study is testing if adding dalpiciclib to hormone therapy can help women with early breast cancer that is hormone receptor-positive and HER2-negative feel better and stay cancer-free.
-
Combining Sintilimab with Chemoradiotherapy for Advanced Gastric Cancer
This study is testing if combining an immunotherapy drug called Sintilimab with chemotherapy and radiotherapy can safely help people with advanced gastric cancer before surgery.
-
Effects of social isolation and interaction on dementia risk in people with subjective cognitive decline
This study is trying to see how being socially isolated or interacting with others affects the risk of dementia in people who notice early signs of memory problems.
-
Evaluating the need for repeat bladder surgery in patients with negative urine biomarker tests
This study is testing if patients with non-muscle-invasive bladder cancer who have negative urine biomarker tests can skip repeat bladder surgery and still do well.
-
Evaluating Pyrotinib dosing for advanced HER2-positive breast cancer
This study is testing if a lower dose of Pyrotinib is safer and just as effective as the standard dose for people with advanced HER2-positive breast cancer.
-
Comparing two pacing methods for heart failure patients
This study is testing whether a new pacing method called conduction system pacing can help heart failure patients just as much as the standard biventricular pacing to improve their heart function.
-
Evaluating immunotherapy for liver cancer in Chinese patients
This study is testing how well immunotherapy treatments work for Chinese patients with liver cancer to see if they are safe and effective in real-life situations.
-
Combination therapy for newly diagnosed acute myeloid leukemia
This study is testing a new combination of drugs to see if it helps adults with newly diagnosed acute myeloid leukemia feel better and improve their treatment outcomes.
-
Neoadjuvant therapy for resectable intrahepatic cholangiocarcinoma
This study is testing a new combination of chemotherapy and targeted therapy to see if it helps people with a specific type of liver cancer avoid recurrence after surgery.
-
Intermittent treatment with darolutamide for metastatic prostate cancer
This study is testing if taking darolutamide in cycles, instead of all the time, can help men with advanced prostate cancer feel better while using other treatments.
-
Comparing catheter ablation and drug therapy for atrial fibrillation in heart failure patients
This study is testing whether a heart procedure called catheter ablation works better than medication for people with atrial fibrillation and heart failure.
-
Combination therapy for advanced gastric cancer with liver or lymph node metastasis
This study is testing a new combination treatment for people with advanced gastric cancer that has spread to the liver or lymph nodes to see if it can help them become tumor-free before surgery.
-
Comparing LOT-CRT and conventional BiVP in heart failure patients with intraventricular block
This study is testing whether a new heart pacing method called LOT-CRT works better than the standard biventricular pacing for people with chronic heart failure and a specific heart block.
-
Combining Disitamb Vedotin and Pyrotinib for HER2-positive Early Breast Cancer
This study is testing if combining two drugs, Disitamb Vedotin and pyrotinib, can help people with early HER2-positive breast cancer who haven't had treatment before.
-
Comparing two treatments for metastatic hormone-sensitive prostate cancer
This study is testing if adding chemotherapy to a hormone treatment can help men with advanced prostate cancer live longer compared to just using hormone treatment alone.
-
Evaluating chidamide for maintaining treatment in PTCL patients
This study is testing if chidamide can help people with peripheral T-cell lymphoma stay in remission after their initial treatment.
-
Comparing short-term and long-term treatment options for advanced prostate cancer
This study is testing if a shorter 6-month treatment with Rezvilutamide and hormone therapy works just as well as a longer treatment for men with advanced prostate cancer.
-
Omitting axillary surgery in breast cancer patients with complete response after treatment
This study is testing if women with breast cancer who have no signs of cancer in their lymph nodes after treatment can safely skip surgery to remove those lymph nodes.
-
Avoiding sentinel lymph node biopsy in early breast cancer patients
This study is testing whether women with early breast cancer can safely skip a specific lymph node surgery to see if it helps them recover better and have less swelling in their arms.
-
Comparing Chi-BEAM and BEAM Regimens for Newly Diagnosed Peripheral T-cell Lymphoma
This study is testing whether a new treatment called Chi-BEAM works better than the standard BEAM treatment for people with newly diagnosed peripheral T-cell lymphoma before they have a stem cell transplant.
-
Maintenance therapy with Venetoclax for elderly patients with acute myeloid leukemia in remission
This study is testing if a medication called Venetoclax can help older patients with acute myeloid leukemia stay in remission and live longer after their initial treatment.
-
Using inhaled nitric oxide to improve exercise capacity in COPD patients
This study is testing if inhaled nitric oxide can help people with moderate to severe COPD exercise better and feel safer while doing it.
-
Using hypovolemic phlebotomy to improve laparoscopic liver surgery outcomes
This study is testing whether a method that involves taking some blood out before liver surgery can help patients with liver cancer have safer surgeries and need fewer blood transfusions.
-
Using Pyrotinib to Reduce Recurrence Risk in Early Stage HER2-positive Breast Cancer
This study is testing if the drug pyrotinib can help reduce the chances of breast cancer coming back in women with early stage HER2-positive breast cancer who haven't fully responded to previous treatments.
-
Using Sodium Bicarbonate Ringer's Solution in Liver Surgery
This study is testing if using sodium bicarbonate Ringer's solution during liver surgery helps patients stay stable compared to the usual lactate Ringer's solution.
-
Combining Azacitidine and Ruxolitinib for treating higher-risk MDS/MPN
This study is testing if combining two medications, Azacitidine and Ruxolitinib, can help people with higher-risk Myelodysplastic Syndromes or Myeloproliferative Neoplasms feel better and improve their health.
-
Nutritional management for patients with esophageal cancer
This study tests if a personalized nutrition plan helps people with esophageal cancer feel better and manage their weight compared to standard nutrition advice.
-
Comparing two treatment approaches for esophageal squamous cell carcinoma
This study is testing whether adding extra chemotherapy to standard treatment can help people with inoperable esophageal squamous cell carcinoma live longer and feel better.
-
Combining camrelizumab and apatinib with TACE for liver cancer treatment
This study is testing if combining two medications with a liver cancer treatment before surgery can help people with liver cancer live longer and have fewer problems after surgery.
-
Using umbilical cord blood stem cells with azacitidine for advanced blood cancers
This study is testing whether using umbilical cord blood stem cells along with a medication called azacitidine can help people with advanced blood cancers who can't have traditional stem cell transplants.
-
Using advanced imaging techniques to improve gastric cancer staging
This study is testing whether advanced imaging techniques can help doctors better stage gastric cancer in patients before surgery to improve their treatment plans.
-
Combination treatment for ctDNA positive gastric cancer
This study is testing a new combination treatment for patients with a specific type of stomach cancer to see if it works better than the usual treatment.
-
Evaluating treatment approaches for Graves' disease management
This study is testing different ways to use methimazole to treat Graves' disease and see how well they work in preventing the condition from coming back after stopping the medication for two years.
-
Using half-dose recombinant staphylokinase before heart procedure for heart attack patients
This study is testing if giving a half-dose of a new heart medication before a heart procedure can help heart attack patients feel better and avoid serious complications.
-
Exploring RD133 for treating relapsed mesothelin-positive solid tumors
This study is testing a new CAR-T cell therapy called RD133 to see if it can safely help people with relapsed mesothelin-positive solid tumors.
-
Evaluating the impact of lymph node dissection on outcomes in high-risk bladder cancer
This study is testing whether removing lymph nodes during bladder cancer surgery helps people with high-risk non-muscle invasive bladder cancer live longer and have fewer complications compared to those who don’t have the lymph nodes removed.
-
Identifying genetic factors for acetaminophen-induced liver injury in Chinese patients
This study is trying to find out if certain genes make Chinese patients more likely to have liver problems from taking acetaminophen.
-
Comparing segmentectomy and lobectomy for small lung tumors
This study is testing whether a lung surgery called segmentectomy is just as good as a larger surgery called lobectomy for people with small lung tumors to see how it affects their chances of staying cancer-free and living longer.
-
Human amniotic-derived mesenchymal stem cell treatment for calciphylaxis
This will try human amniotic-derived mesenchymal stem cells as a treatment for adults 18–75 who have calciphylaxis, including people with chronic kidney disease whether they are on dialysis or not.
-
Combining Lenalidomide with R-DA-EPOCH for Untreated DLBCL with MYC Rearrangement
This study is testing if adding lenalidomide to a specific chemotherapy treatment can help people with untreated diffuse large B-cell lymphoma that has a MYC gene rearrangement.
-
Transanal local excision after radiotherapy vs total mesorectal excision for ultra-low T2N0M0 distal rectal cancer
This study tests whether removing the tumor through a transanal approach after radiotherapy works as well as the standard total mesorectal excision for ultra-low rectal cancer in adults 18–75.
Quick answers
How many clinical trials run by The First Affiliated Hospital with Nanjing Medical University are recruiting right now?
147, as of November 12, 2026. 5 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 52, Phase 3: 9, Phase 4: 8, Early Phase 1: 5. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.